Drugs News and Research

RSS

Pediatricians stand by meds for ADHD, but some say therapy should come first

When children are diagnosed with attention deficit hyperactivity disorder, stimulant medications like Ritalin or Adderall are usually the first line of treatment.

30 Sep 2019

Placebos may lead to mistaken inferences about effects and harms of new treatment

Placebo controls are the 'gold' standard against which new treatments are often measured. If a new treatment consistently proves to be better than a placebo treatment, then it is taken to be effective. Otherwise, it isn't.

30 Sep 2019

Many Italian truck drivers suffer from sleep-related breathing problem, shows survey

A survey of 905 Italian truck drivers has shown that approximately half suffer from at least one sleep-related breathing problem that potentially can cause drivers to fall asleep at the wheel.

30 Sep 2019

Study reveals molecular mechanism of cancer malignancy and development of leukemia

A Waseda University-led research uncovered the molecular mechanism of how a particular cancer-causing oncogene could trigger an onset of acute myeloid leukemia (AML).

30 Sep 2019

Higher dosage of statins can increase risk of osteoporosis, shows study

At low doses, statins could protect against bone resorption. But the higher the dosage of cholesterol-lowering drugs, the greater the probability of osteoporosis, an analysis of millions of patient data by the Complexity Science Hub Vienna shows.

30 Sep 2019

US Government supports Kinoxis Therapeutics to end opioid addiction

Kinoxis Therapeutics has been awarded a grant for a potential of up to $US4.6 million ($6.8 million) under the USA National Institutes of Health Helping to End Addiction Long-Term, or the NIH HEAL Initiative.

30 Sep 2019

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

30 Sep 2019

Adding targeted therapy drug to standard treatment benefits aggressive breast cancer patients

A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.

29 Sep 2019

Additional heart artery stenting can help prevent future heart attacks

Research has shown that patients who have had emergency heart attack treatment with heart artery stenting - and have significant narrowings in their other untreated arteries - can benefit from additional stenting to help prevent future heart attacks.

28 Sep 2019

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden NHS Foundation Trust.

28 Sep 2019

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).

27 Sep 2019

Lipid produced in response to cold helps reduce blood sugar

Researchers based in Brazil, the United States and Germany have discovered that 12-HEPE, a lipid produced in response to cold by brown adipose tissue in the human body, helps reduce blood sugar. The results of their experiments with mice pave the way for new treatments for diabetes.

27 Sep 2019

Novel nanogels could precisely deliver therapeutic treatments to cancer patients

Researchers at The University of Texas at Austin have developed new guidelines for fabricating nanoscale gel materials, or nanogels, that can deliver numerous therapeutic treatments to treat cancer in a precise manner.

27 Sep 2019

High-speed imaging technology reveals previously unseen details of living creatures

The Columbia team behind the revolutionary 3D SCAPE microscope announces today a new version of this high-speed imaging technology.

27 Sep 2019

Healthy neurons form surprising connections with aggressive brain cancer cells

In a collaborative study by the University of Bergen, Universität Heidelberg and Das Deutsche Krebsforschungszentrum in Germany, researchers discovered that cancer cells in the brain communicate with healthy brain cells in a different way than previously assumed.

27 Sep 2019

Functional three-organoid stem cell system could lead to unprecedented advances for precision medicine

Using iPS cells, a Japanese research group has successfully grown a connected set of organs at the same time, including a liver and a pancreas connected by a bile duct.

27 Sep 2019

Research reveals why viruses will need to be reclassified and its biotech impact

New research reveals that the way viruses were perceived in terms of their architecture will need to be retooled, because they are actually structured in many more patterns than previously understood.

27 Sep 2019

New method can improve precision medicine, safety of drug-delivery devices

Researchers at the National Institute of Standards and Technology (NIST) have developed an optical system that accurately measures the flow of extraordinarily tiny amounts of liquids -- as small as 10 billionths of a liter (nanoliters) per minute.

27 Sep 2019

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic awards.

27 Sep 2019

FDA warns about Ranitidine containing known carcinogen NDMA

The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.

26 Sep 2019

Drugs News and Research

Pediatricians stand by meds for ADHD, but some say therapy should come first

Placebos may lead to mistaken inferences about effects and harms of new treatment

Many Italian truck drivers suffer from sleep-related breathing problem, shows survey

Study reveals molecular mechanism of cancer malignancy and development of leukemia

Higher dosage of statins can increase risk of osteoporosis, shows study

US Government supports Kinoxis Therapeutics to end opioid addiction

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Adding targeted therapy drug to standard treatment benefits aggressive breast cancer patients

Additional heart artery stenting can help prevent future heart attacks

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Lipid produced in response to cold helps reduce blood sugar

Novel nanogels could precisely deliver therapeutic treatments to cancer patients

High-speed imaging technology reveals previously unseen details of living creatures

Healthy neurons form surprising connections with aggressive brain cancer cells

Functional three-organoid stem cell system could lead to unprecedented advances for precision medicine

Research reveals why viruses will need to be reclassified and its biotech impact

New method can improve precision medicine, safety of drug-delivery devices

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

FDA warns about Ranitidine containing known carcinogen NDMA

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News